M&A Deal Summary

Qiagen N.V Acquires Biotage - Biosystems Business

On October 1, 2008, Qiagen N.V acquired life science company Biotage - Biosystems Business from Biotage AB for 53M USD

Acquisition Highlights
  • This is Qiagen N.V’s 2nd transaction in the Life Science sector.
  • This is Qiagen N.V’s 7th largest (disclosed) transaction.
  • This is Qiagen N.V’s 4th transaction in the United States.

M&A Deal Summary

Date 2008-10-01
Target Biotage - Biosystems Business
Sector Life Science
Buyer(s) Qiagen N.V
Sellers(s) Biotage AB
Deal Type Divestiture
Deal Value 53M USD

Target

Search 193,974 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Qiagen N.V

Venlo, Netherlands

website


Category Company
Founded 1984
Sector Life Science
Employees5,200
Revenue 1.5B USD (2019)
DESCRIPTION

QIAGEN N.V. is a Netherlands holding company publically traded on NASDAQ and Frankfurt Prime Standard. The Company is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular insights. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Qiagen was founded in 1986 and is based in Venlo, the Netherlands.


DEAL STATS #
Overall 5 of 16
Sector (Life Science) 2 of 7
Type (Divestiture) 1 of 1
Country (United States) 4 of 11
Year (2008) 2 of 2
Size (of disclosed) 7 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-07-01 Corbett Life Science Pty.

Mortlake, Australia

Corbett Life Science Pty. Ltd. is a developer, manufacturer, and distributor of life sciences instrumentation.

Buy $66M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-09-22 DxS

Manchester, United Kingdom

DxS Ltd. is a personalized healthcare company providing molecular diagnostics to aid doctors and drug companies in selecting safe and effective therapies for patients based on their molecular profiles (Companion diagnostics). DxS was formed in 2001 and is headquartered in Manchester, UK.

Buy $130M

Seller(S) 1

SELLER

Biotage AB

Uppsala, Sweden

website


Category Company
Sector Life Science
Employees284
Revenue 490M SEK (2014)
DESCRIPTION

Biotage AB is a Swedish company offering solutions within two fields: pharmaceutical chemistry, conducted in the Discovery chemistry business, and genetic analysis, which makes up the Biosystems business unit.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2008) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-10-06 Separtis Holding AG

Grenzach-Wyhlen, Germany

Separtis Holding AG is a distributor of medical products.

Buy €1M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-04-26 MIP Technologies AB

Lund, Sweden

MIP Technologies AB is a developer of molecularly imprinted polymers (MIPs) and other novel polymers. MIP Technologies commercial applications of MIPs, holds important patents and maintains cutting-edge research activities in this area.

Buy kr16M